Latest filing published 23 Jun 2025 for IRulya Therapeutics Inc., €7,892.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +139.4%Entry US$132.00 · Close at T+365 US$316.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Charles S. Ryan: trading record in brief
Filings by Charles S. Ryan span 3 companies, the busiest being BioRestorative Therapies, Inc., IRulya Therapeutics Inc. and Applied DNA Sciences Inc. We count 6 filings; the first trade dates from 8 May 2015 and the latest from 18 June 2025.
On the market, this insider has only ever bought: 3 purchases, €96k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants.
A typical purchase (the median) is worth €28k.
Most recently, on 23 June 2025, the filings show a share grant worth €7,892 in IRulya Therapeutics Inc. The most recent open-market purchase was published on 22 August 2024, 808 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles S. Ryan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,548 shares@ US$1.2021.8% of flowCommon SharesSEC:0000912282-25-000696:0
- 48,387 shares@ US$0.6578.2% of flowCommon StockSEC:0001415889-24-022054:0Canonical exit: 18 Nov 2024 (T+90)
- 14,205 shares@ US$1.76100.0% of flowCommon StockSEC:0001571049-17-006372:0
- 26,667 shares@ US$3.00100.0% of flowCommon StockSEC:0001140361-17-010429:0
- 6,250 shares@ US$4.00Common StockSEC:0001140361-15-044823:0Canonical exit: 6 Mar 2016 (T+90)
- 200,000 shares@ US$0.25Common StockSEC:0001140361-15-019089:0Canonical exit: 6 Aug 2015 (T+90)
6 of 6 declarations